SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Capital Product Partners L.P. (CPLP) trades at a trailing P/E of 7.8, forward P/E of 9.7. Trailing earnings yield is 12.82%, forward earnings yield 10.35%. PEG 0.08 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (72/100, Pass) — P/E is below market average (7.8); PEG ≤ 1.0 — Peter Lynch undervalued (0.08); earnings yield beats bond yields (12.82%).
- PEG Ratio 0.08 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 12.82% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $17.00 (+1.4% upside) — modest upside expected.
Overall SharesGrow Score: 64/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
72/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CPLP
Valuation Multiples
P/E (TTM)7.8
Forward P/E9.7
PEG Ratio0.08
Forward PEG0.08
P/B Ratio0.00
P/S Ratio0.99
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.15
Forward EPS (Est.)$1.74
Book Value / Share$0.00
Revenue / Share$17.02
FCF / Share$0.00
Yields & Fair Value
Earnings Yield12.82%
Forward Earnings Yield10.35%
Dividend Yield0.00%
Analyst Target$17.00 (+1.4%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$2.17 |
$192.78M |
$44.01M |
22.8% |
| 2015 |
$2.66 |
$220.34M |
$55.41M |
25.1% |
| 2016 |
$2.38 |
$241.62M |
$52.49M |
21.7% |
| 2017 |
$1.54 |
$249.12M |
$38.48M |
15.4% |
| 2018 |
$-0.01 |
$117.6M |
$-104K |
-0.1% |
| 2019 |
$-7.75 |
$108.37M |
$-140.82M |
-129.9% |
| 2020 |
$0.76 |
$140.87M |
$13.76M |
9.8% |
| 2021 |
$4.24 |
$184.67M |
$77.8M |
42.1% |
| 2022 |
$8.94 |
$299.07M |
$172.7M |
57.7% |
| 2023 |
$2.15 |
$360.59M |
$47.21M |
13.1% |
